Literature DB >> 9743620

GTP-dependent conformational changes associated with the functional switch between Galpha and cross-linking activities in brain-derived tissue transglutaminase.

A Monsonego1, I Friedmann, Y Shani, M Eisenstein, M Schwartz.   

Abstract

GTP and Ca2+, two well-known modulators of intracellular signaling pathways, control a structural/functional switch between two vital and mutually exclusive activities, cross-linking and Galpha activity, in the same enzyme. The enzyme, a brain-derived tissue-type transglutaminase (TGase), was recently cloned by us in two forms, one of which (s-TGN) lacks a C-terminal region that is present in the other (l-TGN). Immunoreaction with antibodies directed against a peptide present in the C-terminus of l-TGN but missing in s-TGN suggested that this site, which is located in the C-terminal fourth domain, undergoes conformational changes as a result of interaction between l-TGN and GTP. Site-directed mutagenesis suggested that the third domain is involved in mediating the inhibition of the cross-linking activity. These results were supported by molecular modeling, which further suggested that domains III and IV both participate in conformational changes leading to the functional switch between the Ca2+-dependent cross-linking activity and the Galpha activity. Copyright 1998 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9743620     DOI: 10.1006/jmbi.1998.2052

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  14 in total

1.  Ligand-induced conformational changes in tissue transglutaminase: Monte Carlo analysis of small-angle scattering data.

Authors:  P Mariani; F Carsughi; F Spinozzi; S Romanzetti; G Meier; R Casadio; C M Bergamini
Journal:  Biophys J       Date:  2000-06       Impact factor: 4.033

Review 2.  Cellular functions of tissue transglutaminase.

Authors:  Maria V Nurminskaya; Alexey M Belkin
Journal:  Int Rev Cell Mol Biol       Date:  2012       Impact factor: 6.813

Review 3.  Role of transglutaminase 2 in celiac disease pathogenesis.

Authors:  Cornelius Klöck; Thomas R Diraimondo; Chaitan Khosla
Journal:  Semin Immunopathol       Date:  2012-03-22       Impact factor: 9.623

4.  Cell surface transglutaminase promotes RhoA activation via integrin clustering and suppression of the Src-p190RhoGAP signaling pathway.

Authors:  Anna Janiak; Evgeny A Zemskov; Alexey M Belkin
Journal:  Mol Biol Cell       Date:  2006-02-01       Impact factor: 4.138

5.  Conserved tryptophan in the core domain of transglutaminase is essential for catalytic activity.

Authors:  S N Prasanna Murthy; Siiri Iismaa; Gillian Begg; Douglas M Freymann; Robert M Graham; Laszlo Lorand
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-26       Impact factor: 11.205

6.  Interactions of G(h)/transglutaminase with phospholipase Cdelta1 and with GTP.

Authors:  S N Murthy; J W Lomasney; E C Mak; L Lorand
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-12       Impact factor: 11.205

7.  Role of transglutaminase 2 in liver injury via cross-linking and silencing of transcription factor Sp1.

Authors:  Hideki Tatsukawa; Yayoi Fukaya; Gordon Frampton; Antonio Martinez-Fuentes; Kenji Suzuki; Ting-Fang Kuo; Keisuke Nagatsuma; Kentaro Shimokado; Masataka Okuno; Jian Wu; Siiri Iismaa; Tomokazu Matsuura; Hidekazu Tsukamoto; Mark A Zern; Robert M Graham; Soichi Kojima
Journal:  Gastroenterology       Date:  2009-01-14       Impact factor: 22.682

Review 8.  Transglutaminases: nature's biological glues.

Authors:  Martin Griffin; Rita Casadio; Carlo M Bergamini
Journal:  Biochem J       Date:  2002-12-01       Impact factor: 3.857

Review 9.  Transglutaminase 2 inhibitors and their therapeutic role in disease states.

Authors:  Matthew Siegel; Chaitan Khosla
Journal:  Pharmacol Ther       Date:  2007-05-13       Impact factor: 12.310

10.  Identification of two GTP-independent alternatively spliced forms of tissue transglutaminase in human leukocytes, vascular smooth muscle, and endothelial cells.

Authors:  Thung-S Lai; Yusha Liu; Weidong Li; Charles S Greenberg
Journal:  FASEB J       Date:  2007-07-03       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.